Rafael Amado Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Rafael Amado.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Rafael Amado. Rafael Amado is a Chief Medical Officer in Adaptimmune Therapeutics PLC ($ADAP) and a President, R & D in Adaptimmune Therapeutics PLC ($ADAP) and a President, R&D in Adaptimmune Therapeutics PLC ($ADAP) and a EVP of R&D and CMO in Allogene Therapeutics, Inc. ($ALLO).

Address: 5 ASHWOOD LANE MALVERN 19436 PA

Companies in which Rafael Amado is an Insider

Adaptimmune Therapeutics PLC

Trading Symbol: ADAP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Rafael Amado: President, R&D, President, R & D, Chief Medical Officer
Holdings: 17,237 shares
Current Value: $78,084
Latest Transaction: Aug 07 2019
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Allogene Therapeutics, Inc.

Trading Symbol: ALLO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Rafael Amado: EVP of R&D and CMO
Holdings: 110,035 shares
Latest Transaction: Mar 17 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Rafael Amado

Sentiment: All, ADAP, ALLO

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 17 2021ALLOAllogene Therapeut ...Amado RafaelEVP of R&D and CMOSellS38.052,798106,471110,035112.8 K to 110 K (-2.48 %)
Oct 08 2020ALLOAllogene Therapeut ...Amado RafaelEVP of R&D and CMOSellS39.4016,538651,515111,677128.2 K to 111.7 K (-12.90 %)
Mar 20 2020ALLOAllogene Therapeut ...Amado RafaelEVP of R&D and CMOOption ExerciseA18.22109,6001,996,912109,600
Mar 20 2020ALLOAllogene Therapeut ...Amado RafaelEVP of R&D and CMOGrantA0.0030,8000135,962105.2 K to 136 K (+29.29 %)
Sep 05 2019ALLOAllogene Therapeut ...Amado RafaelEVP of R&D and CMOOption ExerciseA26.15160,6304,200,475160,630
Sep 05 2019ALLOAllogene Therapeut ...Amado RafaelEVP of R&D and CMOGrantA0.00105,1620105,1620 to 105.2 K
Sep 05 2019ALLOAllogene Therapeut ...Amado RafaelEVP of R&D and CMOOption ExerciseA26.15160,6304,200,475160,630

View all Rafael Amado insider transactions.